|
Recent Developments |
|
21-MAR-17
Divis Laboratories, a pharmaceutical ingredients and intermediates company, has received an Import Alert 66-40 from US Food and Drug Administration (USFDA) for its products manufactured at the company's Unit-II located at Visakhapatnam, Andhra Pradesh on March 20, 2017.
15-OCT-15
Non Institutions were holding 14.63 percent stake at the end of September 2015 quarter, up 56 basis points from 14.07 percent as on Jun 30, 2015.
10-AUG-15... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Dec-2018(9) | 31-Mar-2018(12) | 31-Mar-2017(12) | | Net sales | 36232.30 | 19290.80 | 40754.80 | | Other Income | 1634.00 | 987.70 | 550.50 | | Total Income | 37866.30 | 20278.50 | 41305.30 | | Cost of goods sold | -23637.80 | 13257.50 | 27130.80 | | OPBDIT | 61504.10 | 7021.00 | 14174.50 | | PAT | 10433.00 | 4316.40 | 10532.70 | | Gross Block | - | - | - | | Equity capital | - | 530.90 | 530.90 | | EPS (Rs.) | - | - | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 162.4 | 34.6 | 34.3 | | Net margin (% of OI) | 27.6 | 21.3 | 25.5 |
|
|
Detailed Financials
|
|
|
|
|
